Lesion Complexity and Outcomes of Extended Dual Antiplatelet Therapy After Percutaneous Coronary Intervention
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference14 articles.
1. Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents;Mauri;N Engl J Med,2014
2. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines;Levine;J Am Coll Cardiol,2016
3. Development and validation of a stent thrombosis risk score in patients with acute coronary syndromes;Dangas;J Am Coll Cardiol Intv,2012
4. Efficacy and safety of dual antiplatelet therapy after complex PCI;Giustino;J Am Coll Cardiol,2016
5. Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions
Cited by 105 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Antithrombotic Therapy in Patients with Complex Percutaneous Coronary Intervention and Cardiogenic Shock;Interventional Cardiology Clinics;2024-10
2. Contemporary Predictors of Major Adverse Cardiovascular Events Following Percutaneous Coronary Intervention: A Nationally Representative US Sample;Journal of Clinical Medicine;2024-05-11
3. Prevalence and prognostic impact of complex percutaneous coronary intervention among octogenarians;Catheterization and Cardiovascular Interventions;2024-04-19
4. Ticagrelor vs Clopidogrel for Complex Percutaneous Coronary Intervention in Chronic Coronary Syndrome;JACC: Cardiovascular Interventions;2024-02
5. Prognostic Implication of Platelet Reactivity According to Procedural Complexity After PCI;JACC: Asia;2023-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3